Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Rate | 35 | 2018 | 248 | 3.460 |
Why?
|
| Blood Pressure | 13 | 2015 | 613 | 1.120 |
Why?
|
| Stress, Psychological | 11 | 2017 | 541 | 0.820 |
Why?
|
| Electrocardiography | 13 | 2017 | 154 | 0.760 |
Why?
|
| Anemia, Sickle Cell | 2 | 2020 | 169 | 0.730 |
Why?
|
| Biofeedback, Psychology | 1 | 2018 | 6 | 0.680 |
Why?
|
| Laughter | 1 | 2018 | 1 | 0.660 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2007 | 24 | 0.620 |
Why?
|
| Vagus Nerve | 6 | 2017 | 22 | 0.610 |
Why?
|
| Autonomic Nervous System | 8 | 2017 | 36 | 0.530 |
Why?
|
| Aging | 5 | 2009 | 639 | 0.510 |
Why?
|
| Emotions | 5 | 2016 | 204 | 0.500 |
Why?
|
| Depression | 2 | 2018 | 664 | 0.480 |
Why?
|
| Adult | 32 | 2020 | 11034 | 0.430 |
Why?
|
| Models, Cardiovascular | 4 | 2007 | 53 | 0.430 |
Why?
|
| Anxiety | 1 | 2018 | 705 | 0.410 |
Why?
|
| Heart | 8 | 2016 | 178 | 0.410 |
Why?
|
| Female | 37 | 2020 | 19873 | 0.410 |
Why?
|
| Male | 35 | 2018 | 18870 | 0.370 |
Why?
|
| Young Adult | 15 | 2018 | 4012 | 0.360 |
Why?
|
| Blood Pressure Determination | 3 | 2011 | 53 | 0.350 |
Why?
|
| Humans | 46 | 2020 | 34853 | 0.350 |
Why?
|
| Adolescent | 18 | 2018 | 5035 | 0.340 |
Why?
|
| Cardiovascular System | 2 | 2006 | 30 | 0.340 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2004 | 59 | 0.330 |
Why?
|
| Sex Factors | 6 | 2015 | 859 | 0.310 |
Why?
|
| Amobarbital | 2 | 2008 | 2 | 0.300 |
Why?
|
| Hydrocortisone | 4 | 2014 | 72 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2007 | 33 | 0.290 |
Why?
|
| Electroencephalography | 2 | 2018 | 108 | 0.280 |
Why?
|
| Prejudice | 2 | 2006 | 101 | 0.280 |
Why?
|
| Pulsatile Flow | 1 | 2006 | 15 | 0.280 |
Why?
|
| Social Perception | 1 | 2006 | 59 | 0.280 |
Why?
|
| Middle Aged | 21 | 2020 | 9642 | 0.270 |
Why?
|
| Brain Injuries | 1 | 2007 | 104 | 0.260 |
Why?
|
| Stroke Volume | 1 | 2006 | 97 | 0.260 |
Why?
|
| Facial Expression | 2 | 2016 | 21 | 0.250 |
Why?
|
| Prefrontal Cortex | 4 | 2010 | 133 | 0.230 |
Why?
|
| Cognition | 4 | 2014 | 373 | 0.220 |
Why?
|
| Cold Temperature | 1 | 2002 | 39 | 0.220 |
Why?
|
| Hot Temperature | 1 | 2002 | 120 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 3 | 2011 | 71 | 0.210 |
Why?
|
| Smoking | 3 | 2016 | 903 | 0.200 |
Why?
|
| Baroreflex | 2 | 2015 | 9 | 0.200 |
Why?
|
| Depressive Disorder | 2 | 2013 | 166 | 0.190 |
Why?
|
| Regression Analysis | 3 | 2018 | 429 | 0.180 |
Why?
|
| Arousal | 2 | 2011 | 82 | 0.180 |
Why?
|
| Sympathetic Nervous System | 2 | 2011 | 74 | 0.170 |
Why?
|
| Psychophysiology | 1 | 2018 | 13 | 0.160 |
Why?
|
| Fourier Analysis | 5 | 2005 | 40 | 0.160 |
Why?
|
| Serotonin | 2 | 2015 | 114 | 0.160 |
Why?
|
| Hypertension | 5 | 2011 | 770 | 0.160 |
Why?
|
| Anger | 3 | 2007 | 20 | 0.160 |
Why?
|
| Stereotyping | 1 | 2017 | 40 | 0.150 |
Why?
|
| Placebo Effect | 2 | 2015 | 13 | 0.150 |
Why?
|
| Positron-Emission Tomography | 3 | 2011 | 79 | 0.140 |
Why?
|
| Designer Drugs | 1 | 2015 | 2 | 0.140 |
Why?
|
| Saliva | 3 | 2014 | 97 | 0.140 |
Why?
|
| Dextroamphetamine | 1 | 2015 | 10 | 0.140 |
Why?
|
| Circadian Rhythm | 2 | 2015 | 212 | 0.130 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 60 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2018 | 469 | 0.130 |
Why?
|
| Reference Values | 4 | 2009 | 204 | 0.130 |
Why?
|
| Piperazines | 1 | 2015 | 109 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 3 | 2005 | 11 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 126 | 0.130 |
Why?
|
| Sex Characteristics | 3 | 2011 | 213 | 0.130 |
Why?
|
| Brain | 3 | 2011 | 1268 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2015 | 89 | 0.130 |
Why?
|
| Aged | 11 | 2014 | 6448 | 0.130 |
Why?
|
| Posture | 1 | 2014 | 57 | 0.130 |
Why?
|
| Algorithms | 4 | 2005 | 435 | 0.120 |
Why?
|
| Hand Strength | 2 | 2011 | 21 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2007 | 347 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 165 | 0.120 |
Why?
|
| Parasympathetic Nervous System | 2 | 2011 | 8 | 0.120 |
Why?
|
| Personality | 1 | 2013 | 36 | 0.120 |
Why?
|
| Histamine Antagonists | 1 | 2013 | 6 | 0.120 |
Why?
|
| Models, Statistical | 4 | 2010 | 171 | 0.120 |
Why?
|
| Drug Eruptions | 1 | 2013 | 8 | 0.110 |
Why?
|
| Histamine | 1 | 2013 | 17 | 0.110 |
Why?
|
| Face | 1 | 2013 | 49 | 0.110 |
Why?
|
| Robotics | 1 | 2013 | 43 | 0.110 |
Why?
|
| Brain Diseases | 2 | 2010 | 33 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 3 | 2010 | 111 | 0.110 |
Why?
|
| Age Factors | 5 | 2008 | 1007 | 0.110 |
Why?
|
| Perception | 1 | 2013 | 183 | 0.110 |
Why?
|
| Statistics as Topic | 4 | 2010 | 111 | 0.100 |
Why?
|
| Culture | 1 | 2013 | 162 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2017 | 583 | 0.100 |
Why?
|
| Environment, Controlled | 1 | 2010 | 7 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 143 | 0.100 |
Why?
|
| Child | 1 | 2018 | 2875 | 0.100 |
Why?
|
| Occupational Health | 1 | 2010 | 19 | 0.100 |
Why?
|
| Fatigue | 1 | 2011 | 79 | 0.100 |
Why?
|
| Functional Laterality | 3 | 2010 | 75 | 0.100 |
Why?
|
| Carcinoma | 1 | 2011 | 94 | 0.090 |
Why?
|
| Survivors | 1 | 2011 | 126 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 281 | 0.090 |
Why?
|
| Workplace | 1 | 2010 | 72 | 0.090 |
Why?
|
| Exercise | 1 | 2014 | 524 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 2007 | 32 | 0.090 |
Why?
|
| Phobic Disorders | 1 | 2009 | 25 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2010 | 137 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2004 | 555 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 27 | 0.080 |
Why?
|
| Mental Recall | 2 | 2009 | 73 | 0.080 |
Why?
|
| Affect | 2 | 2014 | 147 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 628 | 0.080 |
Why?
|
| Attention | 3 | 2009 | 147 | 0.080 |
Why?
|
| Smoking Cessation | 1 | 2014 | 487 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2009 | 88 | 0.080 |
Why?
|
| Suicide | 1 | 2009 | 114 | 0.080 |
Why?
|
| Expressed Emotion | 1 | 2007 | 6 | 0.080 |
Why?
|
| Statistical Distributions | 1 | 2007 | 3 | 0.080 |
Why?
|
| Tai Ji | 1 | 2006 | 2 | 0.080 |
Why?
|
| Least-Squares Analysis | 1 | 2007 | 42 | 0.080 |
Why?
|
| Analysis of Variance | 4 | 2010 | 528 | 0.070 |
Why?
|
| Vascular Capacitance | 1 | 2006 | 1 | 0.070 |
Why?
|
| Elasticity | 1 | 2006 | 38 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 1 | 2005 | 36 | 0.070 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2004 | 63 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 49 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 106 | 0.070 |
Why?
|
| Pilot Projects | 4 | 2011 | 628 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2007 | 358 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 269 | 0.060 |
Why?
|
| Cues | 2 | 2016 | 54 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2003 | 24 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2004 | 55 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2004 | 188 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 165 | 0.060 |
Why?
|
| Alcoholism | 1 | 2005 | 220 | 0.060 |
Why?
|
| Universities | 2 | 2002 | 363 | 0.050 |
Why?
|
| Movement | 1 | 2003 | 86 | 0.050 |
Why?
|
| Educational Status | 1 | 2004 | 295 | 0.050 |
Why?
|
| Aggression | 1 | 2003 | 75 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 5 | 0.050 |
Why?
|
| Respiration | 1 | 2002 | 49 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2002 | 6 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2011 | 2333 | 0.050 |
Why?
|
| Environment | 1 | 2003 | 130 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2003 | 145 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 490 | 0.050 |
Why?
|
| Risk Factors | 4 | 2015 | 3414 | 0.050 |
Why?
|
| Students | 2 | 2002 | 452 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1426 | 0.050 |
Why?
|
| Nicotine | 1 | 2002 | 238 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2010 | 108 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 255 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2011 | 86 | 0.040 |
Why?
|
| Amygdala | 2 | 2011 | 110 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 1681 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 841 | 0.040 |
Why?
|
| United States | 1 | 2006 | 3894 | 0.040 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2015 | 5 | 0.040 |
Why?
|
| Diastole | 1 | 2015 | 46 | 0.030 |
Why?
|
| Systole | 1 | 2015 | 65 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 901 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2011 | 775 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 130 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 171 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 77 | 0.030 |
Why?
|
| New Zealand | 1 | 2014 | 20 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 102 | 0.030 |
Why?
|
| Smoke | 1 | 2014 | 39 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2011 | 1003 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 232 | 0.030 |
Why?
|
| Adaptation, Physiological | 2 | 2007 | 106 | 0.030 |
Why?
|
| Self Concept | 1 | 2014 | 136 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2013 | 39 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2013 | 38 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 68 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2009 | 2561 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 35 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2011 | 52 | 0.030 |
Why?
|
| Oxygen Radioisotopes | 1 | 2011 | 2 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2011 | 23 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2011 | 49 | 0.020 |
Why?
|
| Motivation | 1 | 2014 | 415 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2011 | 107 | 0.020 |
Why?
|
| Colorado | 1 | 2010 | 13 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 606 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2009 | 14 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 47 | 0.020 |
Why?
|
| Exercise Test | 1 | 2010 | 68 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 292 | 0.020 |
Why?
|
| Executive Function | 1 | 2009 | 47 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 206 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 51 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2008 | 34 | 0.020 |
Why?
|
| Epilepsy | 1 | 2008 | 41 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 292 | 0.020 |
Why?
|
| Cardiography, Impedance | 1 | 2006 | 5 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 254 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2007 | 100 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 468 | 0.020 |
Why?
|
| Feedback | 1 | 2005 | 46 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2005 | 47 | 0.020 |
Why?
|
| Personality Tests | 1 | 2004 | 5 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 98 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2004 | 78 | 0.020 |
Why?
|
| Occupations | 1 | 2004 | 20 | 0.020 |
Why?
|
| Speech | 1 | 2004 | 11 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2004 | 30 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 50 | 0.010 |
Why?
|
| North Carolina | 1 | 2004 | 103 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2004 | 120 | 0.010 |
Why?
|
| Facial Muscles | 1 | 2003 | 6 | 0.010 |
Why?
|
| Twin Studies as Topic | 1 | 2003 | 3 | 0.010 |
Why?
|
| Acceleration | 1 | 2003 | 5 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 13 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2003 | 26 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 2003 | 17 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 49 | 0.010 |
Why?
|
| Transducers | 1 | 2003 | 12 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2003 | 26 | 0.010 |
Why?
|
| Income | 1 | 2004 | 135 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2002 | 38 | 0.010 |
Why?
|
| Sample Size | 1 | 2002 | 28 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 138 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2002 | 75 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 172 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 641 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 284 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 984 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 642 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 14307 | 0.000 |
Why?
|